An exclusive Live Webinar
The Long-Term Impact of COVID-19 on Clinical Trials - What Changes will Remain as Best Practices?
Broadcast has ended. You may watch the replay!
Here is What You'll Learn
Rethinking clinical trials
What initiatives have been implemented in the last few months that originated by out-of-the-box thinking in spite of our regulated industry.
Site support
For many sites, priorities have shifted or new challenges have surfaced. Which site specific activities or knowledge sharing that has supported sites in maintain the running of the trials during this pandemic.
The positive impact
The technologies, activities or services that have seen a swifter implementation or more interest by sponsors that positively impact clinical trials.
Technologies
Which has been the most impactful technology to a small, medium and large CRO during the pandemic.
Direct CRO insights
Our interactive webinar will be joined by several panel members from leading CROs who are sharing their experience.
About Kieran Canisius
Kieran, the CEO and co-founder of Seuss+, brings more than 18 years of industry experience to the table. Her work experiences include leadership and business development roles for leading CROs. Previously, she provided life-science clients with guidance and expertise in strategy.
Kieran is here to genuinely support your organization when facing difficult and important choices as well as developing and implementing comprehensive strategies, even in high-pressure situations. She always channels as much energy and determination into her client’s companies as she does into her own.
About Nicole Stansbury
Nicole Stansbury, Vice President, Central Monitoring Services, joined Syneos Health in February 2019. Nicole has 26 years of experience in the industry beginning as a study coordinator in a multi-therapeutic site followed by 21 years at a large, global CRO where she spent several years as a Clinical Research Associate (CRA) and Project Manager (PM) before moving into leadership roles.
Nicole’s leadership roles included Head of Clinical Management in the Central US where she oversaw Clinical Team Managers (CTMs), CRAs and administrative staff and Head of Global Clinical Performance, a group responsible for clinical metrics, systems, process and quality where Nicole led the development of the risk-based monitoring (RBM) strategy, process and tools.
About Viviënne van de Walle
Viviënne van de Walle studied medicine both at the University of Maastricht and at the University of Oxford. In addition to her MD degree she holds a medical research degree in Genetics, Pediatrics and Genetics.
Viviënne has always combined clinical research with patient care and has been a full-time principal investigator at independent clinical research sites. She co-founded and owns the independent research site PT&R (www.ptr.nu) since 2006. Her entrepreneurship is reflected by her skills as thought leader and in consulting, educating and managing at CROs, pharma, nutritional companies and in executive and advisory board functions at eCOA vendors and trade organizations i.e. ACRP, SCRS, TransCelerate, CISCRIP and the NVFG. With her PT&R-team she was also the proud winner of the inaugural SPRIA EU award of the SCRS.
In 2019 she was nominated for the Clinical Trial Europe - Christine Pierre Life Time Achievement Award and in 2020 she was nominated at the 5th World Congress on Advanced Clinical Trials and Clinical Research for Women in Science Awards / Women Scientist.
About Wanda Meijst
Wanda Meijst studied Biomedical Sciences at the world-renowned Leiden University, and had an extensive clinical research career of over 20 years before joining Siron Clinical as Director of Clinical Operations in 2017.
Her experience and expertise in early and late phase clinical research mean her clients benefit extensively.